Author:
Knight A.,Horsley P.,Yuile A.,Yim J.,Suh M.,Venketesha V.,Kastelan M.,Wheeler H.,Back M.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference26 articles.
1. Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE et al (2020) Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv 2(1):142
2. Yoshimoto K, Hatae R, Sangatsuda Y, Suzuki SO, Hata N, Akagi Y et al (2017) Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Brain Tumor Pathol 34(3):103–112
3. Theeler BJ, Dalal Y, Monje M, Shilatifard A, Suvà ML, Aboud O et al (2020) NCI-CONNECT: comprehensive oncology network evaluating rare CNS tumors-histone mutated midline glioma workshop proceedings. Neurooncol Adv 2(1):007
4. Lowe BR, Maxham LA, Hamey JJ, Wilkins MR, Partridge JF (2019) Histone H3 mutations: an updated view of their role in chromatin deregulation and cancer. Cancers (Basel) 11:5
5. Park C, Kim TM, Bae JM, Yun H, Kim JW, Choi SH et al (2021) Clinical and genomic characteristics of adult diffuse midline glioma. Cancer Res Treat 53(2):389–398
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献